Magdalena Czader, MD
Clinical Pathology/Laboratory Medicine · Indianapolis, INNPI 1720045503
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Beckman Coulter, Inc. accounts for 80.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $5,652 and has fallen 57.8% since, to $2,383 in 2025.
Across 21 payments — averaging $618.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beckman Coulter, Inc.$11K
- Roche Diagnostics Corporation$2K
- Stemline Therapeutics Inc.$67
- Seagen Inc.$33
Across 12 payments — averaging $24,539 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beckman Coulter, Inc.$280K
- Novartis$14K
What the payments were for
- Consulting fees$5,64043%
- Speaking & faculty fees$4,80037%
- Travel & lodging$1,70513%
- Food & beverage$8507%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beckman Coulter, Inc. | 4 | $10,513 |
| Roche Diagnostics Corporation | 15 | $2,383 |
| Stemline Therapeutics Inc. | 1 | $67 |
| Seagen Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DXH 900$4,800
- BenchMark ULTRA$2,139
How this compares
Too few clinical pathology/laboratory medicine providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in Indianapolis
- Jodi ParksIndianapolis$1.3M
- Caroline AnIndianapolis$5K
- Merrill BensonIndianapolis$4K
- Andrew SchadeIndianapolis$2K
- Xiaoyan WangIndianapolis$183
- Stephanie HurwitzIndianapolis$89
- Daniel SmithIndianapolis$81
- Harvey CramerIndianapolis$69
- Thomas DavisIndianapolis$54
- Nichole LepageIndianapolis$40
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.